Advanced search
Publication Cover
Leukemia & Lymphoma Volume 23, 1996 - Issue 1-2
Submit an article Journal homepage
13
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Etoposide and Mitoxantrone as a Second Cycle of Consolidation Therapy Following High Dose Cytosine Arabinoside and Daunorubicin in Patients with Acute Non-Lymphocytic Leukemia in Remission: A Pilot Study

Richard S. Stein Division of Hematology and the Bone Marrow Transplant Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA
,
John P. Greer Division of Hematology and the Bone Marrow Transplant Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA
,
John M. Flexner Division of Hematology and the Bone Marrow Transplant Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA
,
Stacey Goodman Division of Hematology and the Bone Marrow Transplant Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA
&
Steven N. Wolff Division of Hematology and the Bone Marrow Transplant Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Pages 93-98 | Received 20 Jul 1995, Accepted 01 Dec 1995, Published online: 01 Jul 2009

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Richard S. Stein, Steven N. Wolff, John P. Greer, John M. Flexner, Stacey Goodman, Madan Jagasia, Stephen J. Brandt, David S. Morgan, Edward Arrowsmith & Thomas L. McCurley. (2001) Age and Cytogenetics as Predictors of Event Free Survival in Patients with Acute Non-Lymphocytic Leukemia Receiving High Dose Cytosine Arabinoside and Daunorubicin as Consolidation Chemotherapy. Leukemia & Lymphoma 42:5, pages 913-922.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.